Intranasal fractionated administration of desamino-D-arginine vasopressin (DDAVP) in patients with von Willebrand's disease. | Ann Hematol;62(2-3): 81-2, 1991. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Intranasal fractionated administration of desamino-D-arginine vasopressin (DDAVP) in patients with von Willebrand's disease.

Garicochea, B; D'Amico, E A; Bydlowski, S P; Chamone, D A.

Ann Hematol ; 62(2-3): 81-2, 1991.

Article in En | MEDLINE | ID: mdl-1903313

Subject(s)

Deamino Arginine Vasopressin/administration & dosage; von Willebrand Diseases/drug therapy; Administration, Intranasal; Deamino Arginine Vasopressin/therapeutic use; Factor VIII/metabolism; Humans; von Willebrand Diseases/blood

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Von Willebrand Diseases / Deamino Arginine Vasopressin Limits: Humans Language: En Journal: Ann Hematol Journal subject: HEMATOLOGIA Year: 1991 Document type: Article

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Von Willebrand Diseases / Deamino Arginine Vasopressin Limits: Humans Language: En Journal: Ann Hematol Journal subject: HEMATOLOGIA Year: 1991 Document type: Article